Article info
PDFResponse
Why NIPT should be publicly funded
- Correspondence to Eline Maria Bunnik, Medical Ethics, Philosophy and History of Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam 3015 CN, Netherlands; e.bunnik{at}erasmusmc.nl
Citation
Why NIPT should be publicly funded
Publication history
- Received March 17, 2020
- Accepted March 26, 2020
- First published April 10, 2020.
Online issue publication
October 28, 2020
Article Versions
- Previous version (10 April 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Other content recommended for you
- Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access
- Ethics of routine: a critical analysis of the concept of ‘routinisation’ in prenatal screening
- Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis
- Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
- ‘Is it better not to know certain things?’: views of women who have undergone non-invasive prenatal testing on its possible future applications
- Women’s choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England
- Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing
- Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
- Ethical considerations for choosing between possible models for using NIPD for aneuploidy detection
- Comprehensive non-invasive prenatal screening for pregnancies with elevated risks of genetic disorders: protocol for a prospective, multicentre study